IRIS Accounts Production v23.2.0.158 10608974 director 1.3.22 28.2.23 28.2.23 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh106089742022-02-28106089742023-02-28106089742022-03-012023-02-28106089742021-02-28106089742021-03-012022-02-28106089742022-02-2810608974ns10:Originalns15:EnglandWales2022-03-012023-02-2810608974ns14:PoundSterlingns10:Original2022-03-012023-02-2810608974ns10:Originalns10:Director12022-03-012023-02-2810608974ns10:Original2022-03-012023-02-2810608974ns10:Original2023-02-2810608974ns10:Originalns10:PrivateLimitedCompanyLtd2022-03-012023-02-2810608974ns10:Originalns10:SmallEntities2022-03-012023-02-2810608974ns10:Originalns10:AuditExempt-NoAccountantsReport2022-03-012023-02-2810608974ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-03-012023-02-2810608974ns10:SmallCompaniesRegimeForAccountsns10:Original2022-03-012023-02-2810608974ns10:Originalns10:FullAccounts2022-03-012023-02-2810608974ns10:CompanySecretary1ns10:Original2022-03-012023-02-2810608974ns10:Originalns10:RegisteredOffice2022-03-012023-02-2810608974ns10:Original2022-02-2810608974ns10:Originalns5:CurrentFinancialInstruments2023-02-2810608974ns10:Originalns5:CurrentFinancialInstruments2022-02-2810608974ns5:ShareCapitalns10:Original2023-02-2810608974ns5:ShareCapitalns10:Original2022-02-2810608974ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-02-2810608974ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-02-2810608974ns10:Originalns5:FurnitureFittings2022-03-012023-02-2810608974ns10:Originalns5:ComputerEquipment2022-03-012023-02-2810608974ns10:Original2021-03-012022-02-2810608974ns10:Originalns5:FurnitureFittings2022-02-2810608974ns10:Originalns5:ComputerEquipment2022-02-2810608974ns10:Original2022-02-2810608974ns10:Originalns5:FurnitureFittings2023-02-2810608974ns10:Originalns5:ComputerEquipment2023-02-2810608974ns10:Originalns5:FurnitureFittings2022-02-2810608974ns10:Originalns5:ComputerEquipment2022-02-2810608974ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-02-2810608974ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-02-2810608974ns10:Original1ns10:Director12022-02-2810608974ns10:Original1ns10:Director12021-02-2810608974ns10:Original1ns10:Director12022-03-012023-02-2810608974ns10:Original1ns10:Director12021-03-012022-02-2810608974ns10:Original1ns10:Director12023-02-2810608974ns10:Original1ns10:Director12022-02-28
REGISTERED NUMBER: 10608974 (England and Wales)


















UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 28 FEBRUARY 2023

FOR

CONSILIUM BIO LIMITED

CONSILIUM BIO LIMITED (REGISTERED NUMBER: 10608974)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


CONSILIUM BIO LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 28 FEBRUARY 2023







DIRECTOR: Mr T E Allsopp





SECRETARY: Mrs J A Allsopp





REGISTERED OFFICE: Suite 4, East Barton Barns
East Barton Road
Great Barton
Bury St. Edmunds
Suffolk
IP31 2QY





REGISTERED NUMBER: 10608974 (England and Wales)





ACCOUNTANTS: Twinn Accountants Limited
Suite 4, East Barton Barns
East Barton Road
Great Barton
Bury St. Edmunds
Suffolk
IP31 2QY

CONSILIUM BIO LIMITED (REGISTERED NUMBER: 10608974)

BALANCE SHEET
28 FEBRUARY 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 544 724

CURRENT ASSETS
Debtors 5 1,203 4,314
Cash at bank 14,683 15,967
15,886 20,281
CREDITORS
Amounts falling due within one year 6 1,097 2,866
NET CURRENT ASSETS 14,789 17,415
TOTAL ASSETS LESS CURRENT
LIABILITIES

15,333

18,139

PROVISIONS FOR LIABILITIES 103 138
NET ASSETS 15,230 18,001

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 15,130 17,901
SHAREHOLDERS' FUNDS 15,230 18,001

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 28 February 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 28 February 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 6 October 2023 and were signed by:




Mr T E Allsopp - Director


CONSILIUM BIO LIMITED (REGISTERED NUMBER: 10608974)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2023

1. STATUTORY INFORMATION

Consilium Bio Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Furniture & fixtures - 25% on reducing balance
Computer equipment - 25% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2022 - 2 ) .

CONSILIUM BIO LIMITED (REGISTERED NUMBER: 10608974)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 28 FEBRUARY 2023

4. TANGIBLE FIXED ASSETS
Furniture Computer
& fixtures equipment Totals
£    £    £   
COST
At 1 March 2022
and 28 February 2023 919 404 1,323
DEPRECIATION
At 1 March 2022 382 217 599
Charge for year 134 46 180
At 28 February 2023 516 263 779
NET BOOK VALUE
At 28 February 2023 403 141 544
At 28 February 2022 537 187 724

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors - 3,500
Director's current account - 375
Corporation tax 616 -
Prepayments 587 439
1,203 4,314

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Corporation tax - 1,366
Director's current account 23 -
Accrued expenses 1,074 1,500
1,097 2,866

7. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 28 February 2023 and 28 February 2022:

2023 2022
£    £   
Mr T E Allsopp
Balance outstanding at start of year 375 (1,935 )
Amounts advanced 415 2,310
Amounts repaid (813 ) -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (23 ) 375